These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21470379)

  • 1. Accuracy, precision and repeatability in preparing the intravitreal dose with a 1.0-cc syringe.
    Meyer CH; Liu Z; Brinkmann C; Rodrigues EB; Helb HM
    Acta Ophthalmol; 2012 Mar; 90(2):e165-6. PubMed ID: 21470379
    [No Abstract]   [Full Text] [Related]  

  • 2. Compounding bevacizumab for intravitreal injection: does USP <797> always apply?
    Shienbaum G; Flynn HW
    Retina; 2013 Oct; 33(9):1733-4. PubMed ID: 23851633
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of the risk of needlestick injuries associated with intravitreal injections.
    Shah SU; Koenig MJ; Dacquay Y; Mozayan A; Hubschman JP
    Retina; 2014 Apr; 34(4):781-4. PubMed ID: 23975000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal ranibizumab, with or without filter?
    Montero JA; Ruiz-Moreno JM; Sanchis-Merino E
    Acta Ophthalmol; 2012 Aug; 90(5):e405-6. PubMed ID: 22008393
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term stability of bevacizumab repackaged in 1mL polypropylene syringes for intravitreal administration.
    Paul M; Vieillard V; Roumi E; Cauvin A; Despiau MC; Laurent M; Astier A
    Ann Pharm Fr; 2012 May; 70(3):139-54. PubMed ID: 22655582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of compounded bevacizumab prepared for intravitreal injection.
    Yannuzzi NA; Klufas MA; Quach L; Beatty LM; Kaminsky SM; Crystal RG; D'Amico DJ; Kiss S
    JAMA Ophthalmol; 2015 Jan; 133(1):32-9. PubMed ID: 25233052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avastin doesn't blind people, people blind people.
    Gonzalez S; Rosenfeld PJ; Stewart MW; Brown J; Murphy SP
    Am J Ophthalmol; 2012 Feb; 153(2):196-203.e1. PubMed ID: 22264942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new fractioning process to decrease the price of ranibizumab.
    González-Andrades M; Muñoz-Ávila JI; Medarde-Caballero C; Fernández-López C; Damas-Alonso M
    Acta Ophthalmol; 2012 Dec; 90(8):e645-6. PubMed ID: 22520334
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of foreign bodies on the ocular surface after uneventful intravitreal injections.
    Jørgensen JS; Kemp H; Sørensen TL
    Acta Ophthalmol; 2012 Dec; 90(8):e646-7. PubMed ID: 22471425
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of Syringe Design on the Accuracy and Precision of Intravitreal Injections of Anti-VEGF Agents.
    Moisseiev E; Rudell J; Tieu EV; Yiu G
    Curr Eye Res; 2017 Jul; 42(7):1059-1063. PubMed ID: 28306392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Same-day consecutive bilateral intravitreal injections of ranibizumab for the treatment of bilateral active choroidal neovascularization in age-related macular degeneration.
    Shah M; Amoaku WM
    Acta Ophthalmol; 2012 Sep; 90(6):e491-3. PubMed ID: 22269064
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravitreal administration of ranibizumab for idiopathic choroidal neovascularization in a pregnant woman.
    Sarhianaki A; Katsimpris A; Petropoulos IK; Livieratou A; Theoulakis PE; Katsimpris JM
    Klin Monbl Augenheilkd; 2012 Apr; 229(4):451-3. PubMed ID: 22496030
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful management of choroidal metastasis with intravitreal ranibizumab injections.
    Detorakis ET; Agorogiannis G; Drakonaki EE; Tsilimbaris MK; Pallikaris IG
    Ophthalmic Surg Lasers Imaging; 2012 May; 43 Online():e47-51. PubMed ID: 22624796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal ranibizumab injection for choroidal neovascularization in Strümpell-Lorrain Syndrome.
    Tran TH; Baglin G; Querques G
    J Fr Ophtalmol; 2012 May; 35(5):353-5. PubMed ID: 22463854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranibizumab prefilled syringes: benefits of reduced syringe preparation times and less complex preparation procedures.
    Souied E; Nghiem-Buffet S; Leteneux C; Bayer S; Derveloy A; Sagkriotis A; Becker G; Cohen SY
    Eur J Ophthalmol; 2015; 25(6):529-34. PubMed ID: 26044375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new syringe adaptor for intravitreal injection of premature eye.
    Kimura S; Tsukamoto M; Shiode Y; Hosogi M; Morizane Y
    Retina; 2013 Apr; 33(4):889-90. PubMed ID: 23481457
    [No Abstract]   [Full Text] [Related]  

  • 17. Bevacizumab for Intravitreal Injection: Impact of Sub-Visible Particles on the Shelf-Life of Repackaged Bevacizumab.
    Crul M; Zandvliet A; Moes JR; Veenbaas T; Smeets O
    J Ocul Pharmacol Ther; 2019; 35(6):372-375. PubMed ID: 31259653
    [No Abstract]   [Full Text] [Related]  

  • 18. Quality of bevacizumab compounded for intravitreal administration.
    Palmer JM; Amoaku WM; Kamali F
    Eye (Lond); 2013 Sep; 27(9):1090-7. PubMed ID: 23788205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure to detect an effect of pneumatic displacement in the management of submacular haemorrhage secondary to age-related macular degeneration: a retrospective case series.
    Hesgaard HB; Torkashvand M; la Cour M
    Acta Ophthalmol; 2012 Sep; 90(6):e498-500. PubMed ID: 22268661
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term results of intravitreal ranibizumab, intravitreal ranibizumab with photodynamic therapy, and intravitreal triamcinolone with photodynamic therapy for the treatment of retinal angiomatous proliferation.
    Rouvas AA; Chatziralli IP; Theodossiadis PG; Moschos MM; Kotsolis AI; Ladas ID
    Retina; 2012 Jun; 32(6):1181-9. PubMed ID: 22466469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.